Judith Johnson, M.D., has rejoined AMAG Pharmaceuticals as vice president of pharmacovigilance and pharmacoepidemiology, responsible for all pharmacovigilance functions, including product safety surveillance, aggregate safety reporting, pharmacoepidemiology and risk management. She will also oversee the company’s compliance with FDA and regulatory requirements for Feraheme (ferumoxytol) Injection and MuGard Mucoadhesive Oral Wound Rinse.   For the past ten years, Dr. Johnson has held leade...